US 9926602
Recurrent gene fusions in prostate cancer
granted A61PA61P13/08A61P35/00
Quick answer
US patent 9926602 (Recurrent gene fusions in prostate cancer) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P13/08, A61P35/00